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Abstract: In previous studies, the elevated dietary inflammatory index (DII®) scores have been
consistently associated with several chronic diseases. However, the relationship with hyperuricemia
remains unknown. The aim of this study was to determine if the DII is associated with hyperuricemia
risk. The study included 13,701 participants (men 5102; women 8599) in a large-scale cross-sectional
study in South Korea. A validated semi-quantitative food frequency questionnaire (SQFFQ) was
used to measure dietary intake, and blood samples were obtained to determine hyperuricemia.
As the DII score increased, the hyperuricemia risk increased among women (OR 1.35, 95% CI
1.03–1.77, p trend = 0.02). However, no significant results were found for men. Women with lower
BMI scores had higher risks of hyperuricemia with higher DII scores (OR 1.62, 95% CI 1.05–2.52,
p trend = 0.03). As the DII increased, however, only women who consumed alcohol (“past or current
drinkers”) had higher risks of hyperuricemia (OR 1.92, 1.22–3.02, p trend = 0.004). Among the DII
components, intake of flavonoids showed a significant association with the hyperuricemia risk in
women (OR 0.75, 0.59–0.96, p trend = 0.03). Our results suggest that higher intake of pro-inflammatory
diet is significantly associated with higher risk of hyperuricemia among women. These results
reinforce the importance of less pro-inflammatory habitual dietary patterns in lowering the risk of
hyperuricemia and secondary afflictions such as cardiovascular diseases.
Keywords: hyperuricemia; dietary inflammatory index; inflammation; diet; public health
1. Introduction
Uric acid is the final product of purine metabolism in the human body. Hyperuricemia is the state
of excessive uric acid retention. As hyperuricemia can be linked to major disease such as gout, chronic
kidney disease and cardiovascular disease, strategies for its prevention are crucial for improved public
health [1–4]. For example, it was found that 18.8% of hyperuricemic patients experienced gout within
a follow-up period of five years [1], and that hyperuricemia was highly prevalent among those with
renal failure [2]. Additionally, hyperuricemia was found to be strongly associated with cardiovascular
disease [3].
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Chronic inflammation causes a series of systemic reactions, including elevation of acute-phase
proteins, that are related to cardiovascular and periodontal diseases [5–7]. As inflammation occurs,
pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin (IL)-1, and IL-6 are
secreted from the inflammatory cells [5–7]. Uric acid activates the inflammatory NF-κB signaling
pathway and induces inflammatory molecule expression [8,9].
Several studies have found that dietary habits influence the inflammation state [10–13]. The dietary
inflammatory index (DII®), which measures a diet’s inflammatory potential, has been investigated to
evaluate the validity of its association with inflammation markers. DII scores, which are calculated
based on up to 45 food parameters, are based on literature examining the effect of dietary components on
the level on six inflammatory markers (i.e., IL-1β, IL-6, C-reactive protein (CRP), IL-10, IL-4, and TNF-α),
and was validated in studies with different inflammatory biomarkers (i.e., IL-6, high sensitivity CRP
(hs-CRP), fibrinogen, homocysteine, and TNF-α) and populations [14–24]. Previous studies have found
that individuals with high DII scores have significantly higher hs-CRP levels compared with those with
low DII scores [14–20]. This demonstrates that the DII can be used to assess the association between
diet’s inflammatory potential and chronic disease [21–23]. Because there have been no studies on the
potential association of the DII with hyperuricemia risk, the present study used data obtained from the
Korean Genome and Epidemiology Study (KoGES) to investigate this relationship. We hypothesized
that subjects with higher DII scores, indicative of a more pro-inflammatory diet, will have a higher risk
of hyperuricemia.
2. Materials and Methods
2.1. Study Population
Genetic, environmental, and lifestyle determinants of diseases (i.e., hyperuricemia, hypertension,
obesity, osteoporosis, metabolic syndrome, cardiovascular disease, and cancer) among Koreans
were obtained from KoGES, a general population-based prospective cohort study. Detailed
information on its design and aims can be found elsewhere [25]. Among the various population-based
cohorts in KoGES (e.g., KoGES_Ansan and Ansung Study, KoGES_Health Examinee [HEXA] Study,
KoGES_Cardiovascular Disease Association Study [CAVAS]), KoGES_CAVAS data was used in the
present study. The subjects’ were more than 40 years old at baseline, based on the National Health
Examinee registry.
Subjects were asked to volunteer for the study through media campaigns, conferences, letters,
phone calls, and on-site invitations. A total of 13,701 participants (5102 men and 8599 women aged
≥40 years old) were recruited from 11 rural areas in Korea between 2005 and 2011. Of the original 28,338
willing participants, those who had an unreliable daily caloric intake (men <500 or >6000 kcal/day;
women <500 or >4000 kcal/day) and/or no energy information were excluded, bringing the final sample
size down to 13,701 (Figure 1). All of the study participants voluntarily signed a written informed
consent before joining the study, and the study protocol was approved by the Institutional Review
Board of the National Cancer Center (IRB No. NCC2018-0164) as well as the IRBs of the institutions
that had participated in KoGES_CAVAS.
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Figure 1. Flow chart of the study population. KoGES_CAVAS, Korean Genome and Epidemiology 
Study_Cardiovascular Disease Association Study. 
2.2. Data Collection 
All of the study participants provided biomarkers according to standard procedures. The body 
height and weight of the participants were measured with subjects wearing light indoor clothing and 
without shoes. The body-mass index (BMI) was calculated as: weight (kg)/height (m)2. Blood pressure 
was measured on the right arm after resting in a quiet room for 5 min using a standard mercury 
sphygmomanometer (Baumanometer, W.A. Baum Co. Inc., Copiague, NY, USA). With each subject 
seated, a properly sized cuff placed along the mid-arm circumference at the heart level. The arm 
circumference was measured twice at 5 min intervals and the average of the two measurements was 
used. 
Blood samples were collected from all of the study participants after at least 10 h of fasting. For 
long-term storage, the serum and plasma were separated and aliquoted in 6–10 vials (300–500 μL per 
vial), after which all of the samples were transported to the National Biobank of Korea [26]. Laboratory 
evaluations were performed in the same core clinical laboratory that is accredited and participates 
annually in inspections and surveys by the Korean Association of Quality Assurance for Clinical 
Laboratories. Blood concentrations of glucose, TC, HDL-cholesterol, and TG were measured using the 
enzyme method (ADVIA 1650 and ADVIA 1800; Siemens Healthineers, Deerfield, IL, USA). Serum 
concentrations of HDL-cholesterol and TG were determined using enzymatic methods (ADVIA 1650 
Chemistry System, Bayer, Leverkusen, Germany). Hs-CRP was measured using a turbidimetric assay 
method (ADVIA 1650 and ADVIA 1800; Siemens Healthineers). 
During the examination, sociodemographic information, family and personal medical history, 
nutrition intake, and physical activity consistency were obtained. Marital status was stratified into 
those who are married and those who are single/divorced/widowed/separated. Education status was 
divided into three categories: education up to elementary school, middle school to high school, and 
college education or above. Household income levels were divided into four categories: less than 
1,000,000 won, between 1,000,000 and 2,000,000 won, between 2,000,000 and 3,000,000 won, and more 
than 4,000,000 won. With regard to smoking status, those who had smoked more than about 400 
cigarettes and were continuing to smoke at the time of the survey were classified as “current” smokers; 
those who had smoked more than about 400 cigarettes but had stopped smoking by the time of the 
survey were designated as “past” smokers, and those who had not smoked more than 400 cigarettes 
were classified as “never” smokers. Drinking status was divided into three groups: Those who had 
consumed alcohol and were still drinkers at the time of the survey were deemed “current” drinkers; 
those who had consumed alcohol but were abstaining from drinking at the time of the survey were 
designated “past” drinkers, and those who had never consumed alcohol were classified as “never” 
drinkers. Regularity of physical activity was determined according to whether or not subjects 
Figure 1. Flo chart of the study population. KoGES_C VAS, Korean Genome and Epidemiology
Study_Cardiovascular isease ssociation Study.
2.2. Data Collection
All of the study participants provided biomarkers according to standard procedures. The body
height and weight of the participants were measured with subjects wearing light indoor clothing
and without shoes. The body-mass index (BMI) was calculated as: weight (kg)/height (m)2. Blood
pressure was measured on the right arm after resting in a quiet room for 5 min using a standard
mercury sphygmomanometer (Baumanometer, W.A. Baum Co. Inc., Copiague, NY, USA). With each
subject seated, a properly sized cuff placed along the mid-arm circumference at the heart level. The
arm circumference was measured twice at 5 min intervals and the average of the two measurements
was used.
Blood samples were collected from all of the study participants after at least 10 h of fasting.
For long-term storage, the serum and plasma were separated and aliquoted in 6–10 vials (300–500 µL
per vial), after which all of the samples were transported to the National Biobank of Korea [26].
Laboratory evaluations were performed in the same core clinical laboratory that is accredited and
participates annually in inspections and surveys by the Korean Association of Quality Assurance for
Clinical Laboratories. Blood concentrations of glucose, TC, HDL-cholesterol, and TG were measured
using the enzyme method (ADVIA 1650 and ADVIA 1800; Siemens Healthineers, Deerfield, IL, USA).
Serum concentrations of HDL-cholesterol and TG were determined using enzymatic methods (ADVIA
1650 Chemistry System, Bayer, Leverkusen, Germany). Hs-CRP was measured using a turbidimetric
assay method (ADVIA 1650 and ADVIA 1800; Siemens Healthineers).
During the examination, sociodemographic information, family and personal medical history,
nutrition intake, and physical activity consistency were obtained. Marital status was stratified into
those who are married and those who are single/divorced/widowed/separated. Education status
was divided into three categories: education up to elementary school, middle school to high school,
and college education or above. Household income levels were divided into four categories: less
than 1,000,000 won, between 1,000,000 and 2,000,000 won, between 2,000,000 and 3,000,000 won,
and more than 4,000,000 won. With regard to smoking status, those who had smoked more than about
400 cigarettes and were continuing to smoke at the time of the survey were classified as “current”
smokers; those who had smoked more than about 400 cigarettes but had stopped smoking by the
time of the survey were designated as “past” smokers, and those who had not smoked more than
400 cigarettes were classified as “never” smokers. Drinking status was divided into three groups:
Those who had consumed alcohol and were still drinkers at the time of the survey were deemed
“current” drinkers; those who had consumed alcohol but were abstaining from drinking at the time
of the survey were designated “past” drinkers, and those who had never consumed alcohol were
classified as “never” drinkers. Regularity of physical activity was determined according to whether or
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not subjects participated regularly in any sports to the point of sweating. The history of diabetes and
hypertension were indicated as “Yes” if diagnosed.
2.3. Diagnostic Criteria
Hyperuricemia was defined as a serum uric acid level of >7 mg/dL for men and >6 mg/dL for
women, which are similar to the diagnostic criteria used in other studies, including in China [27–29].
A total of 1515 incident hyperuricemia cases were identified.
2.4. Dietary Assessment Using SQ-FFQ and Calculation of DII
To gather information on the subjects’ dietary intakes, they were asked to complete a validated
semi-quantitative food frequency questionnaire (SQFFQ). Detailed information on the SQFFQ is
available elsewhere [30,31]. Based on the SQFFQ, consumption frequencies and average amounts of
106 food items were determined. The frequencies were measured according to nine response categories
ranging from “almost never” to “more than three per day.” Portion size was measured based on three
responses including 1/2 serving, 1 serving, and 3/2 servings. Daily nutrient intake was estimated
by combining obtained information on serving frequency per day, portion per unit for each food
item, and average serving number. The food composition table of the Korean Health and Industry of
Development was used in the calculation of nutrient intake and total energy [32].
Details on the DII are available elsewhere [33]. In short, a high DII score represents a
pro-inflammatory diet and a low DII score represents an anti-inflammatory diet. For the updated DII,
1,943 research articles were reviewed and scored. In developing the DII, a total of 45 food parameters
were scored based on their effects on the levels of six inflammatory markers (i.e., IL-1β, IL-6, CRP,
IL-10, IL-4, and TNF-α). The DII has been validated in studies with different inflammatory biomarkers
(i.e., interleukin (IL)-6, hs-CRP, fibrinogen, homocysteine, and TNF-α) and populations [14–24].
These pro-inflammatory parameters were included: total calories, cholesterol, carbohydrate,
protein, total fat, saturated fatty acids, and vitamin B-12. These anti-inflammatory parameters were
included: vitamin A, vitamin B-6, vitamin C, vitamin D, vitamin E, niacin, magnesium, riboflavin,
beta-carotene, isoflavones, flavan-3-ol, flavanols, flavones, folic acid, fiber, alcohol, ginger, garlic,
pepper, MUFAs, PUFAs, and tea. The present study utilized nutritional content data from the
Functional Ingredients Table (Rural Development Administration), Computer Aided Nutritional
Analysis (The Korean Nutrition Society), and the U.S. Department of Agriculture. From our SQFFQ 37 of
the 45 parameters were available and these were as follows: carbohydrate, protein, fat, fiber, cholesterol,
carotene, caffeine, energy, n-3 fatty acids, n-6 fatty acids, trans fat, saturated fat, mono-unsaturated
fat, poly-unsaturated fat, niacin, thiamin, riboflavin, falvan-3-ol, flavones, flavonols, flavonones,
anthocyanidins, isoflavones, vitamin B12, vitamin B6, iron, magnesium, zinc, selenium, vitamin A,
vitamin C, vitamin D, vitamin E, folic acid, onion, garlic and tea. As a comparative standard for
those parameters, a world database consisting of diet surveys from 11 countries was used [33]. The
DII scores were calculated based on the database’s intake values, the details on which are available
elsewhere [33]. In brief, a standard mean for each parameter from the database was subtracted from
the actual individual exposure. The results were then divided by their standard deviation to generate
Z scores. Those were converted to proportions to minimize the effects of outliers. The proportions
were multiplied by two and then one was subtracted to achieve symmetrical distributions with values
centered around 0. The results were then multiplied by the complementary inflammation score for each
food parameter, which were all summed to obtain the overall DII score. In the DII score calculation,
intakes from both foods and supplements were included. Several studies have found and validated
the association between DII score and inflammatory markers in various populations [14–17,20–24].
2.5. Statistical Analysis
All of the statistical analyses were performed with SAS® 9.3 (SAS Institute, Cary, NC, USA).
For continuous variables such as age (years), energy intake (kcal), BMI, and hs-CRP levels, the results
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were expressed as medians (25%, 75%). Also, the following categorical variables were expressed
as n (%). The chi-square test and t-test were used to compare categorical and continuous variables
according to the case-control status of hyperuricemia. The DII score of the control group was divided
into quartiles according to gender, and the range was applied to the group with hyperuricemia. The
odds ratios and the corresponding 95% confidence intervals (ORs; 95% CIs) were estimated using
logistic regression models, adjusting for age and additionally for smoking status, drinking status,
education, BMI, daily caloric intake, hs-CRP, and region. Tests for trends were performed using DII as
a continuous variable. Stratified analyses were carried out according to BMI and drinking status. The
p value for interaction was calculated by contrasting the coefficients of the cross-product of BMI or
drinking status and DII quartile in the multivariable logistic regression model. Flavonoid intake level
of the DII component was divided into four levels in the control group in women. p values <0.05 were
considered statistically significant.
3. Results
In the present study, 12,186 controls and 1515 hyperuricemia cases were included (Table 1).
The DII scores were higher in female hyperuricemia cases than in controls. Compared with the
controls, the cases were older, heavier (higher BMI), consumed fewer calories, had larger waist
circumferences, and higher hs-CRP, homeostatic model assessment of insulin resistance (HOMA-IR),
glucose and triglyceride. The percentages of past or current smokers and drinkers were higher in men
with hyperuricemia than in women, while the hypertension-history rate was higher in women with
hyperuricemia than in men.
The results of the multivariate logistic analysis suggested that people with hyperuricemia
were more likely to be those in the highest quartile of the DII (Q4) (OR 1.23, 95% CI 1.03–1.46,
p for trend = 0.02). The results also are reported by gender in Table 2. Among women, participants
who had higher DII scores (Q4) had a significantly higher hyperuricemia risk (OR 1.35, 95% CI 1.03–1.77,
p for trend = 0.02). No statistically significant association between DII and hyperuricemia risk was
observed among the men (OR 1.10, 95% CI 0.87–1.39, p for trend = 0.49).
The association between hyperuricemia risk and DII score, as stratified by BMI and drinking
status, was investigated (Table 3). Women with low BMI had higher risk of hyperuricemia for the DII
quartiles (OR 1.62, 95% CI 1.05–2.52, p for trend = 0.03), while no association was found among those
with high BMI scores (OR 1.19, 95% CI 0.84-1.68, p for trend = 0.34). However, a contrasting result was
found among men, for whom there was no statistically significant association between hyperuricemia
risk and DII score (OR 1.02, 95% CI 0.73–1.42, p for trend = 0.96; OR 1.18, 95% CI 0.85–1.67, p for trend
= 0.27) in men with either a low or a high BMI score. Women drinkers showed a significant increase in
hyperuricemia risk (OR 1.92, 95% CI 1.22–3.02, p for trend = 0.004), while no association was found
among non-drinkers (OR 1.12, 95% CI 0.80–1.57, p for trend = 0.48). Among the men, both drinkers
and non-drinkers showed only an insignificant increase in hyperuricemia risk according to their DII
scores (OR 1.05, 95% CI 0.56–1.98, p for trend = 0.83; OR 1.12, 95% CI 0.86–1.42, p for trend = 0.49).
The association between flavonoids intake and hyperuricemia risk in women is shown in Table 4.
High scores for flavan-3-ol, flavones, flavonols and flavonones were found to be significantly associated
with decreased ORs for hyperuricemia risk in the women. Increased flavonoids, which represented the
sum of those four components, were correlated with decreased risk of hyperuricemia (OR 0.75, 95% CI
0.59–0.96, p trend = 0.03).
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Table 1. Characteristics of study participants in KoGES_CAVAS cohort.
Male Female
Characteristics With Hyperuricemia(n = 875)
Without Hyperuricemia




(n = 7959) p Value
Serum uric acid (mg/dL) 8.06 ± 0.99 b 5.32 ± 1.00 <0.0001 6.90 ± 0.85 4.24 ± 0.87 <0.0001
DII −0.01 ± 2.08 −0.08 ± 2.18 0.3610 0.46 ± 2.23 0.13 ± 2.16 0.0002
Age (years) 61.2 ± 10.1 62.2 ± 9.56 0.0035 64.2 ± 9.02 60.5 ± 9.94 <0.0001
BMI (kg/m2) 25.0 ± 3.10 23.8 ± 2.94 <0.0001 25.8 ± 3.64 24.4 ± 3.19 <0.0001
Waist circumference (cm) 88.4 ± 8.41 85.1 ± 8.37 <0.0001 86.5 ± 9.38 82.9 ± 8.93 <0.0001
hs-CRP (mg/L) 2.72 ± 6.48 2.19 ± 5.81 <0.0001 2.62 ± 4.48 1.58 ± 3.96 <0.0001
WBC (Thousand/ µL) 7.04 ± 1.94 6.76 ± 2.00 0.0001 6.99 ± 2.16 6.14 ± 1.79 <0.0001
Glucose (mg/dL) 102 ± 21.8 104 ± 28.8 0.0175 104 ± 24.3 98.2 ± 21.4 <0.0001
HOMA_IR 2.28 ± 2.05 1.86 ± 1.00 0.0265 2.53 ± 1.43 1.93 ± 0.96 <0.0001
SBP (mmHg) 127 (126–128) 125 (124–125) 0.0010 128 (127–130) 124 (123–124) <0.0001
DBP (mmHg) 80.0 (79.3–80.8) 78.9 (78.6–79.2) 0.0027 78.5 (77.7–79.4) 76.8 (76.5–77.0) <0.0001
Triglyceride (mg/dL) 199 (191–208) 154 (151–157) <0.0001 193 (184–201) 141 (139–143) <0.0001
HDL-cholesterol (mg/dL) 41.8 (41.0–42.5) 44.2 (43.8–44.5) <0.0001 42.7 (42.0–43.5) 46.3 (46.0–46.5) <0.0001
Daily caloric intake (kcal) 1694 (1661–1727) 1710 (1694–1726) 0.3980 1443 (1408–1477) 1494 (1484–1504) 0.0051
Carbohydrate intake
(g/day) 308 (303–314) 315 (312–317) 0.0364 276 (269–282) 285 (284–287) 0.0030
Carbohydrate (E%) 73.7 (73.2–74.1) 74.4 (74.2–74.6) 0.0018 77.0 (76.5–77.5) 76.9 (76.8–77.0) 0.7963
Protein intake (g/day) 52.6 (51.2–54.0) 53.0 (52.1–53.5) 0.7806 42.7 (41.3–44.2) 44.4 (44.0–44.8) 0.1894
Protein (E%) 12.2 (12.1–12.4) 12.1 (12.1–12.2) 0.3754 11.7 (11.5–11.9) 11.8 (11.7–11.8) 0.7901
Fat intake (g/day) 24.8 (23.7–25.9) 23.8 (23.4–24.3) 0.1041 16.4 (15.4–17.3) 17.0 (16.7–17.3) 0.0237
Fat (E%) 12.4 (12.1–12.8) 11.9 (11.7–12.0) 0.0023 9.73 (9.35–10.1) 9.79 (9.68–9.89) 0.3891
Fruits (g/day) 146 (136–155) 152 (147–157) 0.2524 170 (157–183) 184 (180–188) 0.0386
Vegetables (g/day) 213 (203–222) 235 (230–240) <0.0001 184 (172–195) 207 (304–210) 0.0001
Marriage
Married 811 (93.2) 3987 (94.8) 0.07 422 (66.0) 5932 (74.8) <0.0001
Single 59 (6.8) 220 (5.2) 217 (34.0) 1999 (25.2)
Education
~Elementary school 397 (45.5) 1998 (47.4) 0.19 474 (74.3) 5524 (69.6) 0.03
Middle~High school 379 (43.5) 1831 (43.5) 142 (22.2) 2149 (27.1)
College~ 96 (11.0) 383 (9.1) 22 (3.5) 270 (3.3)
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Table 1. Cont.
Male Female
Characteristics With Hyperuricemia(n = 875)
Without Hyperuricemia




(n = 7959) p Value
Household Income Levels c
Less than 100 72 (38.1) 366 (38.1) 0.58 97 (57.7) 885 (46.9) 0.01
100~less than 200 38 (20.1) 234 (24.4) 32 (19.1) 383 (20.3)
200~less than 300 35 (18.5) 160 (16.7) 22 (13.1) 263 (13.9)
More than 300 44 (23.3) 200 (20.8) 17 (10.1) 356 (18.9)
Smoking Status
Never 217 (24.8) 1070 (25.3) 0.07 575 (89.8) 7578 (95.3) <0.0001
Past 397 (45.4) 1751 (41.4) 25 (3.9) 144 (1.8)
Current 261 (29.8) 1404 (33.3) 40 (6.3) 234 (2.9)
Drinking Status
Never 135 (15.5) 1011 (23.9) <0.0001 416 (65.10) 5404 (68.0) 0.0008
Past 114 (13.0) 606 (14.4) 41 (6.42) 278 (3.5)
Current 626 (71.5) 2607 (61.7) 182 (28.48) 2268 (28.5)
Physical Activity d
No 594 (67.9) 2842 (67.2) 0.72 435 (68.0) 5526 (69.5) 0.43
Yes 281 (32.1) 1384 (32.8) 205 (32.0) 2429 (30.5)
History of Hypertension
No 556 (63.5) 3193 (75.6) <0.0001 297 (46.4) 5749 (72.2) <0.0001
Yes 319 (36.5) 1033 (24.4) 343 (53.6) 2209 (27.8)
History of Diabetes
No 787 (89.9) 3769 (89.2) 0.51 551 (86.1) 7270 (91.4) <0.0001
Yes 88 (10.1) 457 (10.8) 89 (13.9) 688 (8.6)
DII, Dietary inflammatory index; BMI, body-mass index; hs-CRP, high-sensitivity C-reactive protein; WBC, white blood cell; SBP, systolic blood pressure; DBP, diastolic blood pressure;
HOMA-IR, homeostasis model assessment insulin resistance (fasting insulin × fasting plasma glucose/405); HDL-cholesterol, high-density lipoprotein cholesterol. a Comparisons between
groups without and with hyperuricemia were performed by t-test or Chi-squared tests. b The data are presented as mean ± standard deviation (SD) or mean (95% confidence interval) for
continuous variables and as n (%) for categorical variables. c 10,000 Korean won; 1000 won is about 850 dollars or about the same value in euros. d Regularity of physical activity was
determined according to whether or not subjects participated regularly in any sports to the point of sweating.
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Table 2. Odds ratios (ORs) for hyperuricemia and corresponding 95% CI by quartile of DII scores in KoGES_CAVAS cohort.
Quartile of DII
First (Lowest) Second Third Fourth (Highest) p for Trend a Continuous DII
TOTAL
Range −7.3344~−1.2409 −1.2408~−0.2501 −0.2499~1.5499 1.5513~7.0740
Cases/controls 349/3047 367/3047 391/3047 408/3045
Odds ratio (95% CI)
Crude 1.00 1.05 (0.90−1.23) b 1.12 (0.96–1.31) 1.17 (1.01–1.36) 0.03 1.03 (1.00–1.05)
Multivariate adjusted 1.00 1.05 (0.89–1.25) 1.01 (0.92–1.30) 1.23 (1.03–1.46) 0.02 1.04 (1.01–1.07)
MEN c
Range −7.3344~−1.3572 −1.3565~−0.3522 −0.3520~1.4001 1.4012~6.9009
Cases/controls 212/1057 217/1057 220/1057 226/1056
Odds ratio (95% CI)
Crude 1.00 1.02 (0.83–1.26) 1.04 (0.84–1.28) 1.07 (0.87–1.31) 0.53 1.02 (0.98–1.05)
Multivariate adjusted 1.00 1.03 (0.82–1.29) 1.00 (0.80–1.26) 1.10 (0.87–1.39) 0.49 1.02 (0.98–1.06)
WOMEN
Range −7.3009~−1.1924 −1.1915~−0.1928 −0.1922~1.6153 1.6154~7.0740
Cases/controls 126/1990 148/1989 170/1991 196/1989
Odds ratio (95% CI)
Crude 1.00 1.18 (0.92–1.50) 1.35 (1.06–1.71) 1.56 (1.23–1.96) <0.0001 1.07 (1.03–1.11)
Multivariate adjusted 1.00 1.11 (0.85–1.45) 1.17 (0.90–1.52) 1.35 (1.03–1.77) 0.02 1.04 (0.99–1.01)
Q1 indicates participants having the lowest DII values, the least pro-inflammatory level; Q4 the highest, the most pro-inflammatory level. DII, Dietary inflammatory index. a Tests for
trends were performed for continuous variable using categorical DII scores by quartiles. b Data are presented as odds ratios (ORs) with correspondent 95% confidence intervals (CI) and are
adjusted for gender (for total subjects), smoking status, drinking status, education, body-mass index (BMI), age, caloric per day, history of diabetes, history of hypertension, and region. c p
value for interaction was calculated as the cross-product of gender (men and women) and the continuous DII score in the model was 0.20.
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Table 3. Multivariable adjusted ORs of hyperuricemia and corresponding 95% CI by quartile of DII scores stratified by BMI, drinking in KoGES_CAVAS cohort.
Quartile of DII p for
Subgroup First (Lowest) Second Third Fourth (Highest) Trend a Interaction b Continuous DII
TOTAL
Body-mass index
Cases/controls 134/1747 182/1896 182/1906 216/1974
<25 1.00 1.11 (0.86–1.42) c 1.04 (0.81–1.34) 1.25 (0.97–1.62) 0.12 0.56 1.04 (0.99–1.09)
Cases/controls 214/1299 185/1150 209/1141 192/1069
>=25 1.00 1.02 (0.81–1.29) 1.15 (0.91–1.44) 1.20 (0.94–1.54) 0.09 1.03 (0.99–1.07)
Drinking status
Cases/controls 105/1460 141/1626 155/1610 150/1719
No 1.00 1.13 (0.85–1.50) 1.23 (0.93–1.63) 1.13 (0.84–1.52) 0.41 0.24 1.02 (0.97–1.07)
Cases/controls 244/1586 226/1415 235/1436 258/1322
Yes d 1.00 1.03 (0.83–1.27) 1.03 (0.83–1.27) 1.32 (1.06–1.63) 0.02 1.05 (1.01–1.09)
MEN
Body–mass index
Cases/controls 89/602 115/708 109/722 130/751
<25 1.00 0.98 (0.72–1.35) 0.86 (0.62–1.19) 1.02 (0.73–1.42) 0.96 0.70 1.01 (0.96–1.07)
Cases/controls 122/455 102/348 111/335 96/305
>=25 1.00 1.10 (0.79–1.52) 1.17 (0.85–1.61) 1.18 (0.85–1.67) 0.27 1.03 (0.97–1.09)
Drinking status
Cases/controls 26/246 37/252 44/249 28/264
No 1.00 1.42 (0.79–2.53) 1.73 (0.98–3.07) 1.05 (0.56–1.98) 0.83 0.08 1.01 (0.92–1.12)
Cases/controls 186/810 180/803 176/808 198/792
Yes 1.00 0.97 (0.76–1.25) 0.91 (0.71–1.17) 1.12 (0.86–1.42) 0.49 1.02 (0.98–1.07)
WOMEN
Body-mass index
Cases/controls 41/1146 61/1173 74/1192 95/1229
<25 1.00 1.26 (0.81–1.95) 1.33 (0.87–2.06) 1.62 (1.05–2.52) 0.03 0.67 1.09 (1.01–1.16)
Cases/controls 85/843 87/816 96/799 101/758
>=25 1.00 1.02 (0.73–1.43) 1.09 (0.78–1.52) 1.19 (0.84–1.68) 0.34 1.01 (0.96–1.07)
Drinking status
Cases/controls 82/1265 101/1362 113/1359 120/1418
No 1.00 1.06 (0.76–1.48) 1.11 (0.80–1.53) 1.12 (0.80–1.57) 0.48 0.21 1.01 (0.96–1.07)
Cases/controls 44/725 47/623 56/631 76/567
Yes 1.00 1.22 (0.77–1.94) 1.31 (0.84–2.06) 1.92 (1.22–3.02) 0.004 1.11 (1.03–1.19)
Q1 indicates participants having the lowest DII values, the least pro-inflammatory level; Q4 the highest, the most pro-inflammatory level. DII, Dietary inflammatory index. a Tests for
trends were performed for continuous variables using categorical DII scores by quartiles. b P for interaction was calculated by contrasting the coefficients of the cross-product of stratified
values and DII quintiles in the model. c Data are presented as odds ratios (ORs) with correspondent 95% confidence intervals (CI) and are adjusted for gender (for total subjects), smoking
status, drinking status, education, body-mass index (BMI), age, caloric per day, history of diabetes, history of hypertension, and region. d Represents past or current drinking.
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Table 4. Multivariable adjusted ORs of hyperuricemia and corresponding 95% CI by quartile of flavonoids of DII components in women in KoGES_CAVAS cohort.
Quartile of Components
DII components
(Flavonoids) First (lowest) Second Third Fourth (highest) P for trend
a
Flavan-3-ol (mg)
Cases/controls 190/1990 167/1990 147/1990 136/1989
Multivariate adjusted 1.00 0.89 (0.71–1.12) b 0.85 (0.68–1.08) 0.78 (0.61–0.99) 0.04
Flavones (mg)
Cases/controls 183/1990 163/1989 167/1990 127/1990
Multivariate adjusted 1.00 0.95 (0.76–1.20) 0.97 (0.77–1.22) 0.75 (0.59–0.96) 0.04
Flavonols (mg)
Cases/controls 181/1989 164/1990 166/1990 129/1990
Multivariate adjusted 1.00 0.94 (0.75–1.18) 0.98 (0.78–1.23) 0.76 (0.59–0.97) 0.06
Flavonones (mg)
Cases/controls 196/1989 150/1991 161/1989 133/1990
Multivariate adjusted 1.00 0.83 (0.66–1.05) 0.89 (0.71–1.11) 0.75 (0.59–0.95) 0.04
Flavonoids (mg)
Cases/controls 187/1990 165/1989 156/1991 132/1989
Multivariate adjusted 1.00 0.92 (0.74–1.16) 0.90 (0.71–1.13) 0.75 (0.59–0.96) 0.03
Q1 indicates participants having the lowest DII values, the least pro-inflammatory level; Q4 the highest, the most pro-inflammatory level. DII, Dietary inflammatory index; Flavonoids =
flavan-3-ol+flavones+flayonols+flayonones. a Tests for trends were performed for continuous variables using categorical component scores by quartiles. b Data are presented as odds
ratios (ORs) with correspondent 95% confidence intervals (CI) and are adjusted for smoking status, drinking status, education, body-mass index (BMI), age, history of diabetes, history of
hypertension, and region.
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4. Discussion
The present cross-sectional study based on data from the KoGES_CAVAS cohort aimed to explore
the association between DII score, which represents diet-based inflammatory state, and hyperuricemia
risk. The study found that higher DII scores (more pro-inflammatory diets) were associated with higher
risk of hyperuricemia among women. Women in the highest DII score quartile (=Q4) had a 22% higher
risk of hyperuricemia than those in the lowest DII score quartile (=Q1) after adjusting for potential
confounders. The results of the current study were consistent with our hypothesis, which is that diet’s
inflammatory potential can influence hyperuricemia risk. We assumed that in a state of inflammation,
the body makes more uric acid or cannot excrete uric acid properly, which leads to hyperuricemia.
In turn, hyperuricemia may worsen the state of inflammation, which condition can lead to gout or other
autoimmune diseases. As the physiological mechanism of inflammation’s causative role with respect
to hyperuricemia is not yet clearly known, future studies should be designed to address this issue.
The present study also found a statistically significant association between the DII and increased
hyperuricemia risk among women with a BMI lower than 25 kg/m2; a finding which does not coincide
with the results of previous studies that found a positive correlation between uric acid level and
obesity [34–37]. However, other studies found that being either overweight or underweight was
associated with higher inflammation in various populations, which might explain why women with
low BMI scores had a significantly positive result for the relation of DII with hyperuricemia risk [38,39].
In any case, further research that can confirm the present results is called for.
Additionally, the present study found a statistically significant association between the DII and
hyperuricemia risk among women drinkers. Previous studies had found that ethanol intake increases
serum uric acid level via both decreased urate excretion and increased production [40–43]. Additionally,
beer and serum uric acid are positively related due to beer’s high purine contents [42], which might
explain the enhanced risk of hyperuricemia among those who consumed alcohol. Alcohol gets an
anti-inflammatory score on the DII. Across all of the papers that were reviewed, alcohol, on average,
exerted an anti-inflammatory effect. It is important to note that these effects are seen within the
normal physiologic range. Of course, severe abuse of alcohol, which exerts a pro-inflammatory effect,
is ill-advised. Additionally, when considering diet’s inflammatory potential, overall diet is key, and if
people are consuming high amounts of alcohol, then it could mean that they are also consuming high
amounts of carbohydrates and energy, which have pro-inflammatory scores on the DII.
The present study also found that hyperuricemia risk decreased as the quartile of flavonoids,
which are DII components, increased. Flavonoids are products of the secondary metabolism of many
edible plants. Flavonoids intake is inversely associated with cardiovascular disease, type 2 diabetes
mellitus, hypertension, stoke risk, myocardial infarction, coronary heart disease, nonalcoholic fatty liver
disease, dementia, and colorectal cancer [44–53]. Various studies on flavonoids suggest that they are
antioxidants that are able to reduce free radical formation as well as the number of free radicals [54,55].
Oxidative stress is known to activate a variety of transcription factors, such as inflammatory cytokines,
that can lead to the expression of various genes [56]. It is associated with activation of reactive oxygen
species, which are supplemented by antioxidants such as flavonoids to reduce cellular oxidants, which,
in turn, can prevent hyperuricemia. One study reported that flavonoids are related to ã-aminobutyric
acid type A (GABAA) receptor for preventing alcohol use disorders [57]. We also performed a joint
analysis of alcohol consumption and flavonoid intake for the risk of hyperuricemia. The results showed
that the interaction of alcohol consumption and flavonoid intake was not significant (p = 0.23, data
not shown), and the combined effect was significant, but it was similar to these factors’ respective
single effects.
In the present study, the association between the DII and hyperuricemia risk differed by gender.
While statistically significant results were shown among the women participants, no such results
were observed among the men. Also in the subgroup analyses, statistically significant results were
shown only among the women participants. Whereas there are no available studies on the association
between the DII and the hyperuricemia risk that could be used for comparison, there has been some
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research stressing the importance of estrogen in promoting excretion of uric acid [58–60]. Estrogen,
in fact, has been hypothesized to have a protective anti-inflammatory effect [61,62]. As the mean age of
the present study’s women participants was older than the mean age at menopause among Korean
women (49.2 years), the number of postmenopausal women in this study might have been the majority;
if so, the results on hyperuricemia risk well might have been skewed higher [63]. Another important
factor to consider is the role of tobacco smoke as a pro-inflammatory agent. It may be that the effect of
tobacco swamps the effect of dietary sources of inflammation [64]. The fact that men smoked at about
10 times the rate of women in this study (75% of men were past or present smokers vs. only about 7%
of women) may help to explain the sex differences observed in our study. More research on the issue of
whether DII affects the risk of hyperuricemia only in women is needed.
Underlying our observations and understanding from all of the many studies that have been
conducted to date using the DII are two countervailing effects [33,65,66]. The first is a tendency to
eat more of everything as one increases caloric intake; this results in a positive correlation between
caloric intake and nutrient intake. The other is the “healthy eater” effect (e.g., due to the intention
of careful, health-conscious people to choose nutrient-dense, energy-sparse foods in preference to
calorie-dense, nutrient-sparse foods). This type of eater produces data that results in negative
correlations between caloric density and nutrient density. In this study, we anticipated the former to be
happening; hence, we saw higher DII scores among women with hyperuricemia but lower values of
not only pro-inflammatory components like energy and macronutrients but also fruits that contain
vital micronutrients and other bio active compounds considered to be anti-inflammatory. In the DII
calculation, there is no differentiation between complex and simple carbohydrates, and there is no
overall inflammatory effect score for it, because when the literature search was done for carbohydrates,
we did not find many articles demarcating them. A similar approach was used for proteins, as there
was not enough research demarcating protein from animal proteins. However, these demarcations will
again be considered in the next iteration of the DII, which will be developed sometime in the future.
There are three limitations to the present study, which should be duly considered in considering
its results. First, the research participants were recruited in 11 rural areas of the National Health
Examination Registry, but only those willing to participate were enrolled; consequently, more women
enrolled than men; their proportion in this study does not represent the general population. This
sort of screening bias occurs in many prospective cohort studies [67]. Second, possible confounding
variables existed and could have affected the outcome. The present study adjusted for sex, smoking
status, drinking status, education, BMI, age, daily caloric intake, CRP and region, which are potential
confounding, as they affect both exposure and outcome. However, there may be variables that can
affect hyperuricemia, such adiposity (expressed as a sum of skinfold thickness measurements) or
creatinine levels [68]. Third, the questionnaire-derived data utilized in this study might not accurately
reflect the subjects’ usual dietary intakes. The questionnaire contains a list of limited food items,
and individuals cannot accurately report food intake retrospectively over a long period of time. Even
with these limitations, the present study highlights the potential harmful effects of pro-inflammatory
dietary patterns with respect to hyperuricemia risk. The results underline the importance of consuming
a more anti-inflammatory diet as a strategy to lower the risk of hyperuricemia.
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